vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $493.8M, roughly 2.8× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 1.4%, a 5.4% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs -1.7%). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (2.8% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
MD vs SEM — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $1.4B |
| Net Profit | $33.7M | $20.2M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 4.6% |
| Net Margin | 6.8% | 1.4% |
| Revenue YoY | -1.7% | 6.4% |
| Net Profit YoY | 10.5% | 225.7% |
| EPS (diluted) | $0.40 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $1.4B | ||
| Q3 25 | $492.9M | $1.4B | ||
| Q2 25 | $468.8M | $1.3B | ||
| Q1 25 | $458.4M | $1.4B | ||
| Q4 24 | $502.4M | $1.3B | ||
| Q3 24 | $511.2M | $1.3B | ||
| Q2 24 | $504.3M | $1.3B | ||
| Q1 24 | $495.1M | $1.3B |
| Q4 25 | $33.7M | $20.2M | ||
| Q3 25 | $71.7M | $28.8M | ||
| Q2 25 | $39.3M | $40.6M | ||
| Q1 25 | $20.7M | $56.7M | ||
| Q4 24 | $30.5M | $-16.1M | ||
| Q3 24 | $19.4M | $55.6M | ||
| Q2 24 | $-153.0M | $77.6M | ||
| Q1 24 | $4.0M | $96.9M |
| Q4 25 | 9.9% | 4.6% | ||
| Q3 25 | 13.8% | 5.4% | ||
| Q2 25 | 12.8% | 6.5% | ||
| Q1 25 | 7.0% | 8.3% | ||
| Q4 24 | 7.8% | 1.6% | ||
| Q3 24 | 6.6% | 4.3% | ||
| Q2 24 | -31.3% | 5.8% | ||
| Q1 24 | 3.2% | 9.0% |
| Q4 25 | 6.8% | 1.4% | ||
| Q3 25 | 14.5% | 2.1% | ||
| Q2 25 | 8.4% | 3.0% | ||
| Q1 25 | 4.5% | 4.2% | ||
| Q4 24 | 6.1% | -1.2% | ||
| Q3 24 | 3.8% | 4.4% | ||
| Q2 24 | -30.3% | 6.1% | ||
| Q1 24 | 0.8% | 7.3% |
| Q4 25 | $0.40 | $0.17 | ||
| Q3 25 | $0.84 | $0.23 | ||
| Q2 25 | $0.46 | $0.32 | ||
| Q1 25 | $0.24 | $0.44 | ||
| Q4 24 | $0.37 | $-0.12 | ||
| Q3 24 | $0.23 | $0.43 | ||
| Q2 24 | $-1.84 | $0.60 | ||
| Q1 24 | $0.05 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $26.5M |
| Total DebtLower is stronger | $570.5M | $1.8B |
| Stockholders' EquityBook value | $865.9M | $1.7B |
| Total Assets | $2.2B | $5.9B |
| Debt / EquityLower = less leverage | 0.66× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $26.5M | ||
| Q3 25 | $340.1M | $60.1M | ||
| Q2 25 | $224.7M | $52.3M | ||
| Q1 25 | $99.0M | $53.2M | ||
| Q4 24 | $229.9M | $59.7M | ||
| Q3 24 | $103.8M | $191.5M | ||
| Q2 24 | $19.4M | $111.2M | ||
| Q1 24 | $8.0M | $92.6M |
| Q4 25 | $570.5M | $1.8B | ||
| Q3 25 | $577.2M | $1.7B | ||
| Q2 25 | $583.9M | $1.8B | ||
| Q1 25 | $590.5M | $1.8B | ||
| Q4 24 | $597.1M | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.8B |
| Q4 25 | $865.9M | $1.7B | ||
| Q3 25 | $890.7M | $1.7B | ||
| Q2 25 | $833.8M | $1.7B | ||
| Q1 25 | $789.2M | $1.7B | ||
| Q4 24 | $764.9M | $1.7B | ||
| Q3 24 | $732.5M | $1.9B | ||
| Q2 24 | $706.5M | $1.4B | ||
| Q1 24 | $856.2M | $1.4B |
| Q4 25 | $2.2B | $5.9B | ||
| Q3 25 | $2.2B | $5.7B | ||
| Q2 25 | $2.1B | $5.7B | ||
| Q1 25 | $2.0B | $5.7B | ||
| Q4 24 | $2.2B | $5.6B | ||
| Q3 24 | $2.1B | $8.0B | ||
| Q2 24 | $2.0B | $7.9B | ||
| Q1 24 | $2.2B | $7.9B |
| Q4 25 | 0.66× | 1.06× | ||
| Q3 25 | 0.65× | 1.03× | ||
| Q2 25 | 0.70× | 1.10× | ||
| Q1 25 | 0.75× | 1.03× | ||
| Q4 24 | 0.78× | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× | ||
| Q1 24 | — | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $64.3M |
| Free Cash FlowOCF − Capex | — | $5.2M |
| FCF MarginFCF / Revenue | — | 0.4% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | 3.39× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $64.3M | ||
| Q3 25 | $137.3M | $175.3M | ||
| Q2 25 | $137.2M | $110.3M | ||
| Q1 25 | $-117.5M | $-3.5M | ||
| Q4 24 | $133.0M | $125.4M | ||
| Q3 24 | $91.8M | $181.0M | ||
| Q2 24 | $107.0M | $278.2M | ||
| Q1 24 | $-125.2M | $-66.7M |
| Q4 25 | — | $5.2M | ||
| Q3 25 | — | $122.2M | ||
| Q2 25 | — | $45.6M | ||
| Q1 25 | — | $-55.8M | ||
| Q4 24 | — | $62.0M | ||
| Q3 24 | — | $130.3M | ||
| Q2 24 | — | $222.6M | ||
| Q1 24 | — | $-119.2M |
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 9.0% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | -4.1% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 17.4% | ||
| Q1 24 | — | -9.0% |
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | 4.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | 4.0% |
| Q4 25 | 3.39× | 3.19× | ||
| Q3 25 | 1.91× | 6.09× | ||
| Q2 25 | 3.49× | 2.72× | ||
| Q1 25 | -5.66× | -0.06× | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 3.25× | ||
| Q2 24 | — | 3.59× | ||
| Q1 24 | -31.03× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
